Using mouse cranial muscles to investigate neuromuscular pathology in vivo

Neuromuscular Disorders

Volumn 20, Issue 11, 2010, Pages 740-743

  Murray, L M ^a   Gillingwater, T H ^a   Parson, S H ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Abductor auris longus; Auricularis superior; Interscutularis; Levator auris longus

Indexed keywords

ABDUCTOR AURIS LONGUS MUSCLE; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AURICULARIS SUPERIOR MUSCLE; CONTROLLED STUDY; CRANIAL MUSCLE; DIAPHRAGM; GASTROCNEMIUS MUSCLE; IN VIVO STUDY; INTERSCUTULARIS MUSCLE; LEVATOR AURIS LONGUS MUSCLE; MOUSE; MUSCLE DEVELOPMENT; NEUROMUSCULAR DISEASE; NONHUMAN; PRIORITY JOURNAL; RODENT; SKELETAL MUSCLE; SOLEUS MUSCLE;

ANIMALS; EAR; MICE; MUSCLE, SKELETAL; NEUROMUSCULAR DISEASES; NEUROMUSCULAR JUNCTION;

EID: 77957750125     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2010.06.013     Document Type: Article

References (23)

1. Macdermot V. The histology of the neuromuscular junction in dystrophia myotonica. Brain 1961, 84:75-84.
2. Zacks S.I., Bauer W.C., Blumberg J.M. Abnormalities in the fine structure of the neuromuscular junction in patients with myasthenia gravis. Nature 1961, 190:280-281.
3. Tsujihata M., Hazama R., Yoshimura T., Satoh A., Mori M., Nagataki S. The motor end-plate fine structure and ultrastructural localization of acetylcholine receptors in amyotrophic lateral sclerosis. Muscle Nerve 1984, 7:243-249.
4. Murray L.M., Comley L.H., Thomson D., Parkinson N., Talbot K., Gillingwater T.H. Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum Mol Genet 2008, 17:949-962.
5. Ramji N., Toth C., Kennedy J., Zochodne D.W. Does diabetes mellitus target motor neurons?. Neurobiol Dis 2007, 26:301-311.
6. Prineas J. The pathogenesis of dying-back polyneuropathies: II. An ultrastructural study of experimental acrylamide intoxication in the cat. J Neuropathol Exp Neurol 1969, 28:598-621.
7. Lu J., Tapia J.C., White O.L., Lichtman J.W. The interscutularis muscle connectome. PLoS Biol 2009, 7:e32.
8. Schaefer A.M., Sanes J.R., Lichtman J.W. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J Comp Neurol 2005, 490:209-219.
9. Pun S., Sigrist M., Santos A.F., et al. An intrinsic distinction in neuromuscular junction assembly and maintenance in different skeletal muscles. Neuron 2002, 34:357-370.
10. Murray L.M., Lee S., Baumer D., Parson S.H., Talbot K., Gillingwater T.H. Pre-symptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy. Hum Mol Genet 2010, 19:420-433.
11. Angaut-Petit D., Molgo J., Connold A.L., Faille L. The levator auris longus muscle of the mouse: a convenient preparation for studies of short- and long-term presynaptic effects of drugs or toxins. Neurosci Lett 1987, 82:83-88.
12. Brown M.C., Holland R.L., Hopkins W.G., Keynes R.J. An assessment of the spread of the signal for terminal sprouting within and between muscles. Brain Res 1981, 210:145-151.
13. Angaut-Petit D., Molgo J., Faille L., Juzans P., Takahashi M. Incorporation of synaptotagmin II to the axolemma of botulinum type-A poisoned mouse motor endings during enhanced quantal acetylcholine release. Brain Res 1998, 797:357-360.
14. Fratantoni S.A., Dubrovsky A.L., Uchitel O.D. Uptake of immunoglobulin G from amyotrophic lateral sclerosis patients by motor nerve terminals in mice. J Neurol Sci 1996, 137:97-102.
15. Garcia N., Santafe M.M., Tomas M., Lanuza M.A., Tomas J. Short-term effects of beta-amyloid 25-35 peptide aggregates on transmitter release in neuromuscular synapses. J Neuropathol Exp Neurol 2008, 67:250-259.
16. Lanuza M.A., Garcia N., Santafe M., Nelson P.G., Fenoll-Brunet M.R., Tomas J. Pertussis toxin-sensitive G-protein and protein kinase C activity are involved in normal synapse elimination in the neonatal rat muscle. J Neurosci Res 2001, 63:330-340.
17. Voss A.A. Extracellular ATP inhibits chloride channels in mature mammalian skeletal muscle by activating P2Y1 receptors. J Physiol 2009, 587:5739-5752.
18. Murray L.M., Thomson D., Conklin A., Wishart T.M., Gillingwater T.H. Loss of translation elongation factor (eEF1A2) expression in vivo differentiates between Wallerian degeneration and dying-back neuronal pathology. J Anat 2008, 213:633-645.
19. Murray L.M., Talbot K., Gillingwater T.H. Neuromuscular synaptic vulnerability in motor neuron disease: amyotrophic lateral sclerosis and spinal muscular atrophy. Neuropathol Appl Neurobiol 2010, 36:133-156.
20. Ruiz R., Casanas J.J., Torres-Benito L., Cano R., Tabares L. Altered intracellular Ca2+ homeostasis in nerve terminals of severe spinal muscular atrophy mice. J Neurosci 2010, 30:849-857.
21. Erzen I., Cvetko E., Obreza S., Angaut-Petit D. Fiber types in the mouse levator auris longus muscle: a convenient preparation to study muscle and nerve plasticity. J Neurosci Res 2000, 59:692-697.
22. Parson S.H., Ribchester R.R., Davie N., Gandhi N.P., Malik R.Q., Gillingwater T.H., et al. Axotomy-dependent and -independent synapse elimination in organ cultures of Wld(s) mutant mouse skeletal muscle. J Neurosci Res 2004, 76:64-75.
23. Baxter R.L., Gillingwater T.H., Parson S.H. Rapid loss of motor nerve terminals following hypoxia-reperfusion injury occurs via mechanisms distinct from classic Wallerian degeneration. J Anat 2008, 212:827-835.